Skip to content

Clinical trials

Completed Uterine Cervical Neoplasms trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Cervical Neoplasms Status: Completed Country / region: Japan Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20072
20081
20091
20102
20131
20141
20151
20182
20191
20204
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC3
EMD Serono Research & Development Institute, Inc.2
AstraZeneca1
Daiichi Sankyo Co., Ltd.1
GOG Foundation1
Genmab1
GlaxoSmithKline1
Grupo Español de Investigación en Cáncer de Ovario1
Haruhiko Fukuda1
Incyte Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Cervical Neoplasms19
Carcinoma, Hepatocellular3
Endometrial Neoplasms3
Ovarian Neoplasms3
Stomach Neoplasms3
Carcinoma, Non-Small-Cell Lung2
Recurrence2
Small Cell Lung Carcinoma2
Squamous Cell Carcinoma of Head and Neck2
Urinary Bladder Neoplasms2

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.